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Abstract
Glutamate and its synthetic analogues N-methyl-D-aspartate (NMDA), kainate, and alpha-amino-3-
hydroxy-5-methylisoxazole-4-propionate (AMPA) are potent dilator agents in the cerebral
circulation. The close linkage between neural activity-based release and actions of glutamate on
neurons and the related decrease in cerebral vascular resistance is a classic example in support of the
concept of tight coupling between increased neural activity and cerebral blood flow. However,
mechanisms involved in promoting cerebral vasodilator responses to glutamatergic agents are
controversial. Here we review the development and current status of this important field of research
especially in respect to cerebrovascular responses to NMDA receptor activation.
Keywords
Glutamate; cerebral circulation; cerebral arteries; nitric oxide; neurons; ischemia; NMDA receptors;
rats; rabbits; piglets
1. Introduction
Glutamate is one of the most prevalent neurotransmitters in the brain (Bonvento et al., 2002;
Kang et al., 2005; Fellin et al., 2006) and it can activate a number of ionotropic receptors on
neurons and astroglia (Garthwaite, 1991; Aoki et al., 1997; Guerguerian et al., 2002). The three
types of ionotropic glutamatergic receptors are characterized by the names of their synthetic
analogues: N-methyl-D-aspartate (NMDA), kainate, and alpha-amino-3-hydroxy-5-
methylisoxazole-4-propionate (AMPA) (McDonald et al., 1990; Garthwaite et al., 1991;
Lerma et al., 1997). Activation of ionotropic glutamatergic receptors on neurons leads to
calcium entry, membrane depolarization, activation of intracellular signaling pathways, and
the subsequent production and release of vasoactive agents which can diffuse to vascular
smooth muscle and dilate cerebral arteries (Garthwaite, 1991; Domoki et al., 2002). Under
some circumstances, additional neurons or astroglia may be involved in transmitting or
modifying the initial signal from the target neurons to the resistance blood vessels in brain
Corresponding author: David W. Busija, Ph.D., Department of Physiology and Pharmacology, Wake Forest University Health Sciences,
Medical Center Boulevard, Winston-Salem, NC USA 27157-1010, Phone: 336-716-4355, Fax: 336-716-0237, Email:
dbusija@wfubmc.edu.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers
we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting
proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could
affect the content, and all legal disclaimers that apply to the journal pertain.
NIH Public Access
Author Manuscript
Brain Res Rev. Author manuscript; available in PMC 2008 November 1.
Published in final edited form as:
Brain Res Rev. 2007 November ; 56(1): 89–100.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
(Filosa et al., 2004; Fellin et al., 2006; Filosa et al., 2006). Recent evidence suggests that
activation of the metabotropic glutamate receptors situated on the astrocytes also produce rapid
vasodilation of nearby arterioles (Zonta et al., 2003).
The linkage between neural activity-based release and actions of glutamate on parenchymal
cells, and the associated decrease in cerebral vascular resistance, provide for the tight coupling
between cerebral metabolism and blood flow. However, the chemical nature of the dilator
agents and the relative roles of neurons, astroglia, and endothelium in promoting dilator
responses have become controversial (Domoki et al., 2002; Fiumana et al., 2003; Zonta et
al., 2003; Simandle et al., 2005; Ayata & Moskowitz, 2006; Leffler et al., 2006 a,b). The
purpose of this review is to critically examine the literature concerning the factors mediating
glutamatergic-mediated dilation in the circulation of the cerebral cortex.
2. Defining the “Playing Field” for responses to glutamatergic agents
The most comprehensive approach for examining the mechanisms involved in glutamatergic
effects on the cerebral circulation is to consider the cerebral blood vessels, astroglia, and
neurons as functionally inter-related components of the “neuronal-vascular axis,” as originally
introduced in 1998 (Veltkamp et al., 1998; Domoki et al., 1999a), or as the more recently
designated “neurovascular unit” (Hawkins and Davis, 2005) (Figure 1). The tight coupling of
brain metabolism and blood flow is a well established concept (Roy and Sherrington, 1890)
and provides the functional basis for the neurovascular unit (Busija and Leffler, 1987a; Busija,
et al., 1988). However, the precise inter-relationships among the components of the
neurovascular unit, which account for metabolism/blood flow coupling, is only now being
defined for various stimuli. In particular, the potential for a prominent role of astroglia (Filosa
et al., 2004; 2006; Mulligan and MacVicar, 2004; Zonta, et al., 2003; Koehler et al., 2006;
Lalo et al., 2006) and interneurons (Cauli et al., 2004; Vaucher et al., 2000; Rancillac et al.,
2006) in conveying signals between neurons and blood vessels has been described recently
using several novel approaches. Interneurons have access to parenchymal arterioles but
apparently not to arterioles and arteries proximal to the appearance of the Virchow-Robin space
(Abadia-Fenoll, 1969; Busija 1993; Lovick et al., 1999). These interneurons may be involved
in vascular signaling from either other local neurons or from projections from distant neurons.
Virtually the entire parenchymal segment of the cerebral vasculature is surrounded by astroglial
end feet, and this anatomical arrangement is one component of the blood-brain barrier
(Hawkins and Davis, 2005; Abbott et al., 2006). While the surface of pial cerebral arteries and
arterioles are not usually thought to be invested with astroglia (Mercier and Hatton, 2002), they
are positioned over the glia limitans (Niermann et al., 2001) and thus can be influenced by
glial-derived factors released into the cerebrospinal fluid (CSF) which is in contact with the
blood vessels. A recent report indicates that astroglia, detected with immunostaining against
glial fibrillary acidic protein (GFAP), are present in surface arterioles and small arteries from
the cerebral circulation of piglets (Leffler et al., 2006a). However, additional studies using
other approaches are needed to support this unusual finding. The ubiquitous positioning of the
astroglia among cerebral blood vessels and neurons and the well known intercellular
interactions involving these cells, appear optimal for rapid and integrated control of vascular
tone in order to meet metabolic demands (Figure 1). Cortically-derived astroglial cells are avid
producers of prostaglandins and thromboxane (Nam et al, 1996; Thore et al., 1994; 1996) and
cerebral arteries normally located close to cortical astroglia are responsive to even small
concentrations of dilator and constrictor prostanoids (Busija and Leffler, 1987b; Leffler and
Busija, 1985; Wagerle and Busija, 1990). In particular, the profile of prostanoids produced by
cerebral arteries varies considerably from that produced by cortical astrogial of the same
species (Busija, 1997; 2002) and thus the CSF bathing the cerebral arteries contains substantial
amounts of vasoactive prostanoids arising from the brain parenchyma. Other studies have
shown that astroglia and neurons can produce and release a wide range of vasodilator
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substances such as nitric oxide (NO) carbon monoxide (CO), adenosine, hydrogen ion,
potassium ion, cyclooxygenase, lipoxygenase, and p-450 monooxygenase products (Bhardwaj
et al., 2002; Zonta et al., 2003; Filosa et al., 2006; Koehler et al., 2006; Leffler et al., 2006a;
Murphy et al., 1994; Ohata et al., 2006). Neuronal- and astroglial-derived factors can act
directly on vascular smooth muscle (Domoki et al., 2002; Filosa et al., 2006) or can act
indirectly via endothelium-dependent dilator agents (Murphy et al., 1994). In some brain
preparations such as cerebellar slices, astrocytes can also release vasoconstrictor agents
(Mulligan and MacVicar, 2004; Rancillac et al., 2006). Recent studies in retina indicate that
glial cells can produce both constrictor and dilator agents through omega-hydroxylase and
cytochrome P450 epoxygenase pathways, repectively (Metea and Newman, 2006; Metea et
al., 2007).
3. Studies of glutamatergic agonists in intact brain
3.1. Responses during normal conditions
Busija and Leffler (1989) were the first to demonstrate that glutamate and its synthetic
analogue, N-methyl-D-aspartate (NMDA) are dilator agents in the intact cerebral circulation
(Table 1). Glutamate and NMDA, when applied to the exposed surface of the piglet cerebral
cortex, dilated overlying pial arterioles in a dose-dependent fashion and these responses were
unaffected by blockade of prostaglandin synthesis. The control mechanisms of the cerebral
circulation and stage of cortical neuronal development of the neonatal pig appear to be similar
to the human neonate (Busija, 2002). Dilator responses to glutamate and NMDA were
repeatable several times in the same preparation following removal of these agents by flushing
with artificial cerebrospinal fluid (aCSF) (Busija and Leffler, 1989; Busija et al., 1996; Philip
and Armstead, 2003) and even prolonged application to the cortical surface did not appear to
damage the cortex in vivo or affect pial arteriolar responses to other, non-glutamatergic dilator
stimuli (Busija and Leffler, 1989). These findings concerning repeatable dilator responses to
glutamate and NMDA, which imply little or no damage to arterioles or cortex are in contrast
to studies on cultured cerebral endothelium (Sharp et al., 2005; Parfenova et al., 2006) or
neurons (Nagy et al., 2004) where glutamate or NMDA can be toxic. Numerous studies by
several laboratories have repeated the essential features of these response to glutamate and
NMDA in piglets (Armstead et al., 2001; Philip and Armstead, 2003; Leffler et al., 2006a). In
addition, all of the original studies in piglets with glutamate and NMDA have been replicated
numerous times in other species such as the rat (Bhardwaj et al., 2000, Iliff et al., 2003,
Pelligrino et al., 1995; 1996; Sun et al., 2005) and rabbit (Faraci and Breese, 1993). Thus, the
fundamental finding that glutamate and NMDA elicit cerebrovascular dilation in vivo appears
to be a universal finding across species. In contrast to these studies, Huang et al. (1994) has
reported that NMDA and glutamate constrict cortical arteries in the rat. The reason for this
unusual finding by Huang et al. (1994) is not clear.
Faraci and Breese (1993) first demonstrated that dilation to NMDA was eliminated or reduced
by treatment with the general NOS inhibitor, Nω-nitro-L-arginine (L-NAME) in rabbits. These
results were later been confirmed in the piglet (Meng et al., 1995; Bari et al., 1996) and in the
rat (Pelligrino et al., 1995; 1996). Subsequent studies published in the same year for piglet and
rabbit showed that administration of 7-nitroindazole (7-NI), the selective inhibitor of neuronal
NOS (nNOS), abolished or reduced dilation to NMDA or glutamate (Faraci and Brian, 1995;
Meng et al., 1995). Thus, another similar finding in all species studied is that NOS inhibition
reduces or eliminates cerebrovascular dilation to NMDA and glutamate. Support for these
pharmacological studies was the finding that NMDA application to the cortex resulted in
accumulation of NO degradation products in the CSF surrounding the arteries (Domoki et
al., 2002). The presence of an underlying vein under the pial arteriole under study reduced its
ability to dilate to NMDA compared to an arteriole directly on the cortical surface (Domoki
et al., 2002), thereby further reinforcing the concept that diffusion of a vasoactive, possibly
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gaseous substance from the cortical surface reaching the arteriole caused the dilation. Robinson
et al., (2002) have reported that 1-aminocyclopropanecarboxylic acid (ACPD), which they
characterized as a NMDA receptor agonist, dilates piglet pial arterioles. However, depending
upon the exact configuration of this compound (trans-/cis-/racemic), which was not specified
in the paper, it could also act as a glycine receptor agonist and/or a glutamate-site antagonist
at NMDA receptors (Nahum-Levy et al., 1999; Peterson et al., 2004). We are unaware of any
other in vivo cerebral circulatory studies in any other species using this compound.
Although glutamate has the potential to exert vasoactive influences via activation of any of the
three ionotropic glutamate receptors, topical application to the surface of the cerebral cortex
appears to predominantly activate the NMDA receptors. Thus, MK-801, a selective NMDA
receptor antagonist, blocks most if not all of the cerebral dilator response to glutamate as well
as NMDA in rabbits, piglets, and rats (Faraci and Breese, 1993; Meng et al., 1995; Pelligrino
et al., 1995;1996). The reason for this preference for the NMDA receptors in the cortex is not
known, but may be due to their location in the cerebral cortex or greater affinity for glutamate
than kainate or AMPA receptors. Administration of the sodium channel blocker tetrodotoxin,
an agent which does not usually affect the endothelium (Emerson and Segal, 2001), completely
eliminates NMDA-induced dilation in vivo in piglet (Leffler et al., 2006a), rabbit (Faraci and
Breese, 1993), and rat (Pelligrino et al., 1996) cerebral arterioles and arteries. However, dilator
responses of cerebral resistance vessels to glutamate were reported to be intact in piglets despite
the presence of tetrodotoxin (Leffler et al., 2006a).
Despite several recent reports (Fiumana et al., 2003; Parfenova et al., 2001; 2003), it is
questionable that the primary effects of glutamate and NMDA receptor agonists represent
direct, endothelium-dependent effects on arteries and arterioles. Isolated cerebral arteries in a
number of species have not been found to dilate in response to application of glutamate or
NMDA (Faraci and Breese, 1993; Simandle et al., 2005) and endothelial damage in vivo failed
to affect NMDA-induced dilation while responses to other endothelium-dependent dilator
stimuli were blocked (Domoki et al., 2002). Furthermore, the absence of functional NMDA
and AMPA receptors in rat and human cerebromicrovascular endothelial cells has also been
demonstrated (Morley et al., 1998).
Consistent with a direct role on parenchyma, glutamate application increased cortical metabolic
rate in proportion to calculated changes in cerebral vascular resistance (Armstead et al.,
1992). NMDA-induced dilation also apparently does not involve activation of perivascular
nerves, since blockade of muscarinic and CGRP receptors does not affect the cerebral vascular
dilator response to topical NMDA in rabbits (Faraci and Breese, 1994).
Application of kainate and AMPA receptor agonists also results in dilation of cerebral arteries
in all species studied when applied to the cerebral cortex, but these agents have not been as
extensively studied in this context as have glutamate and NMDA. Kainate leads to prolonged
dilator responses in piglets that are partially blocked equally by indomethacin and L-NAME,
but not by adenosine or NMDA receptor antagonists (Bari et al., 1997). Similarly, kainate-
induced dilation of cerebral arterioles is reduced by NOS inhibition in rabbits (Faraci et al.,
1994). Garthwaite et al. (1989) have reported that kainate leads to production of NO by brain.
It also appears that antagonists or blockers of heme oxygenase also reduce dilation to kainate
(Ohata et al., 2006) or to the kainate receptor agonist, (RS)-2-amino-3-(3-hydroxy-5-t-
butylisoxazol-4-yl)propionic acid (ATPA) (Robinson et al., 2002). AMPA application leads
to cerebrovascular dilation which reportedly is reduced with inhibitors of heme oxygenase
(Ohata et al., 2006; Robinson et al., 2002) and adenosine receptor blockade (Ohata et al.,
2006). Bhardwaj et al. (1997) has reported that AMPA application leads to cortical production
of NO. Thus, activation of all three types of glutamatergic ionotropic receptors in cerebral
cortex leads to activation of nNOS and production of NO.
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Activation of glutamatergic receptors on neurons and astroglia in the cerebellum also promotes
vascular dilation. The relative contribution of the AMPA and NMDA receptors to vasodilation
appears to be different than in the cerebral cortex probably due to the regional distribution of
these receptor subtypes. Effects of glutamatergic stimuli on the cerebellar arteries and arterioles
are discussed in detail in several relevant papers (Akgoren et al., 1997; Rancillac et al.,
2006; Yang and Iadecola, 1996; Yang et al., 1999). For example, both electrical stimulation
of parallel fibers in the cerebellum, which causes release of glutamate, and the microinjection
of glutamate to this region, increases blood flow in part via activation of AMPA receptors and
subsequent production and actions of neuronally-derived NO (Yang and Iadecola, 1996). In
contrast, activation of stellate cells or application of NMDA dilates cerebellar arteries via
production and actions of NO (Rancillac et al., 2006).
3.2 Altered responses during pathological conditions
Maintenance of metabolism/blood flow in the brain may be disrupted by pathological
conditions (Table 1). Several groups have found that cerebrovascular dilator responses to
glutamatergic agonists can be changed by a variety of experimental conditions in all species
studied. For example, cerebrovascular dilation to NMDA is reduced or eliminated in various
species following asphyxia (Busija and Wei, 1993), alcohol administration (Mayhan and
Didion, 1995), hyperglycemia (Mayhan and Patel, 1995), ischemia/reperfusion (Busija et al.,
1996), hypoxia/reoxygenation (Bari et al., 1996;1998), and traumatic brain injury (Armstead,
2000) via mechanisms largely dependent upon production and actions of reactive oxygen
species (ROS) such as superoxide anion (Bari et al., 1996;Philip and Armstead, 2003;2004).
The primary site of action of the ROS appears to be at the level of the NMDA receptor (Kim
et al., 1999;Choi and Lipton, 2000;Guerguerian et al., 2002) since dilator responses of pial
arterioles are still intact to exogenous NO after ischemic stress (Busija et al., 1996) (Figure 1).
Attenuation of NMDA-induced dilator responses can be prevented by pre-treatment with
activators of plasma membrane or mitochondrial KATP channels (Veltkamp et al.,
1998;Domoki et al., 1999), cyclooxygenase inhibitors (Busija et al., 1996;Domoki et al.,
2001), protein synthesis inhibitors (Veltkamp et al., 1999), and superoxide dismutase (Bari et
al., 1996). In contrast to these findings with NMDA, kainate-induced cerebral arteriolar dilation
is resistant to ischemic stress (Bari et al., 1997). This finding may indicate that kainate receptors
are present on ischemia-resistant neurons and astroglia or that kainate receptors are not readily
affected by actions of ROS. We are unaware of studies examining effects of ROS-mediated
stresses on AMPA-induced dilation.
4. Mechanisms of dilation
The combined results from many investigators in different species have lead to the proposal
that NMDA receptor stimulation in cortical neurons results in calcium influx, membrane
depolarization, activation of intracellular nNOS, and the subsequent production of NO, which
diffuses to cerebral arteries and arterioles and causes relaxation of vascular smooth muscle
without the involvement of astroglia or endothelium (Bari et al., 1998; Domoki et al., 1999;
Faraci and Breese, 1993; Faraci and Brian, 1995; Meng et al., 1995; Pelligrino et al.,1996;
Veltkamp et al., 1998) (Figure 1).
Immunohistochemistry of the piglet brain revealed a particularly distinct band of NMDA
receptors (NMDAR 2A/B) containing neurons in cortical layer II/III interspersed with large
nNOS-positive neurons (Bari et al., 1998). NMDAR 2A/B-nNOS double-immunopositive
neurons usually were not found, or at least were not prominent at the light microscopy level.
Unlike cortical neurons in culture, a situation in which almost all the mature neurons contain
NMDA receptors and nNOS (Kim et al., 1999), NMDA receptors are restricted to more limited
populations of neurons in cerebral cortex and may or may not be co-localized with nNOS
depending upon anatomical location, developmental stage, or species studied (Aoki et al.,
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1997; Bari et al., 1998; Gracy and Pickel, 1997). In particular, Aoki et al., (1997) detailed the
difficulty and uncertainty of fully evaluating dual NMDA receptor and nNOS localization in
neurons in the sensory cortex at the light and electron microscopic levels. Thus, it seems likely
that additional neurons, or possibly astroglia, are involved in the transmission of the dilator
signaling from the activated neurons possessing NMDA receptors to blood vessels. This view
is reinforced by pharmacological results from rats (Bhardwaj et al., 1997) indicating that
NMDA-induced brain production of NO involved not only neurons with NMDA-receptors but
also those with AMPA-receptors. We are unaware of any additional studies which have
examined the relationship between NMDA-receptor and nNOS containing neurons in the
cerebral cortex. Based upon well known age- and species- differences in cerebrovascular
control mechanisms, it is not surprising that part of the dilator responses to NMDA in rats may
be due to production and release of other substances such as adenosine (Iliff et al., 2003) or
P-450 monooxygenase metabolites (Bhardwaj et al., 2002) (Figure 1). However, we could find
no evidence that adenosine (Bari et al., 1998), prostaglandins (Busija and Leffler, 1989), or
P-450 monooxygenase products (Domoki et al., 2002) contribute substantially to NMDA-
induced cerebral arterial dilation in piglets. Nonetheless, the common finding is that one or
more dilator agents, primarily arising from cortical neurons, mediate the dilator responses to
NMDA, which is consistent with the probable involvement of multiple neurons or sequential
signaling pathways.
The lack of principal involvement of astroglia as initiators of NMDA-induced cerebral dilation
is indicated by the ability of tetrodotoxin to totally block the response to topically applied
NMDA (Farci and Breese, 1993; Pelligrino et al., 1995; Leffler et al., 2006a) and by the
persistence of the dilator response to NMDA despite destruction of the glia limitans (Leffler,
CW, personal communication). Tetrodotoxin does not normally impair astroglia-initiated
responses or endothelium-dependent dilation (Emerson and Segal, 2001). The ability of
astroglia to produce large amounts of vasoactive prostaglandins (Busija 1997; Busija 2003;
Nam et al, 1996; Thore et al., 1994; 1996) and the lack of effect of indomethacin on NMDA-
or glutamate-induced cerebral arteriolar dilation in piglets (Busija and Leffler, 1989), provides
additional evidence that astroglia do not play a role in conveying or modifying signaling
between NMDA receptor containing neurons and vascular smooth muscle. Several studies in
diverse species (rat, cat, piglet, cow, man) fail to show significant dilator effects of NMDA
and glutamate on isolated cerebral arteries (Faraci and Breese, 1993; Hardebo et al., 1989;
Simandle et al., 2005; Takayasu and Dacey, 1989; Wendling et al., 1996). Additionally,
impairment of endothelial function does not affect pial arterial and arteriolar dilation in vivo
to topical application of NMDA (Domoki et al., 2002). Again, the lack of direct effects of
NMDA or glutamate in cerebral resistance vessels appears to be a common finding among the
species studied.
The magnitude of the increase in NO production upon NMDA application probably is
underestimated by measurements of degradation products in perivascular CSF (Domoki et
al., 2002) because a high percentage of the NO generated by neurons is prevented from reaching
the pial vessels by reactions with iron containing substances such as hemoglobin and by other
cellular components. This assumption is supported by the finding that arteriolar segments being
“shielded” from the parenchyma by an underlying large vein show significantly smaller
dilatory responses to NMDA (Domoki et al., 2002). Nonetheless, it appears that NO is able to
diffuse considerable distances in healthy cortical tissue to exert vascular effects.
It has been suggested that endothelium-derived NO plays a permissive role in carbon monoxide
(CO)-mediated dilator responses to glutamate and NMDA receptor agonists in the piglet
cerebral circulation (Barkoudah et al., 2004; Leffler et al., 2006b). Therefore, L-NAME may
not only block NO-dependent responses but those involving CO as well. In our studies using
7-NI, which blocked both glutamate and NMDA-induced dilator responses in arterioles (Meng
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et al., 1995), endothelial NOS would still be functionally intact and capable of generating
substantial amounts of vascular NO from resistance and capacitance vessels as well as
capillaries and thus provide the necessary background levels of NO for CO production. If NO
is necessary to allow the expression of CO-mediated dilation to glutamatergic receptor
agonists, then is unclear why 7-NI abolishes cerebral vascular dilation to glutamate and
NMDA. In contrast to the results in piglets, CO has been shown to be a tonic suppressor of
NO-dependent dilation in the rat cerebral circulation via inhibition of NOS activity (Ishikawa
et al., 2005). Ishikawa et al. (2005) also found a similar mechanism operating in cultured
porcine endothelial cells.
5. Controversies
Two recent publications have challenged the concept that glutamate- or NMDA-mediated
dilator responses involve sequential stimulation of neuronal NMDA receptors, activation of
nNOS, and direct relaxation of vascular smooth muscle by NO. First, Ayata and Moskowitz
(2006) have reported that NMDA application elicits cortical spreading depression (CSD) which
complicates the elucidation of mechanism involved in NMDA-induced cerebral vasodilation.
Second, Fiumana et al., (2003) have reported that glutamate and a NMDA receptor agonist are
able to dilate isolated arteries via production and actions of CO.
5.1. Contribution of cortical spreading depression to NMDA-mediated responses
Ayata and Moskowitz (2006) have suggested an alternative mechanism concerning NMDA-
induced cerebrovascular responses in mice. Based upon electrophysiological recordings, they
propose that the cerebrovascular responses to topical NMDA represents a complex response
due to overlapping vasoactive influences associated with CSD-related effects and direct effects
of NMDA on individual neurons (Ayata and Moskowitz, 2006). Such a mechanism is plausible
since it was shown earlier by other authors (Lauritzen and Hansen, 1992; Lauritzen, 1994) that
propagation of CSD is promoted by neuronal release of glutamate and subsequent activation
of NMDA receptors on neighboring neurons. Whether a similar complex interaction between
CSD and direct effects on neurons by NMDA also occurs in other species with lissencephalic
brains such as rats and rabbits in unclear. L-NAME treatment in rats fails to affect
cerebrovascular responses to CSD (Fabricius et al., 1995; Shimizu et al., 2002) while dilator
responses to topical NMDA are reduced or eliminated following acute NOS blockade in this
species (Pelligrino et al., 1996). Similarly, in rabbits, nNOS-derived NO and calcitonin gene-
related peptide released from perivascular nerves contribute equally to CSD-induced dilation
of pial arterioles (Colonna et al., 1993; 1994; 1997) while topical application of 100 μM NMDA
is completely abolished by inhibition of NOS (Faraci and Breese, 1993).
CSD probably does not occur in piglet brain or in other gyrencephalic brains from other species
in response to glutamate or NMDA for several reasons. Cortical spreading depression is not
easily invoked in piglet cortex or in the neonatal brain in general and the pattern of dilation to
NMDA is not consistent with that seen with CSD (Busija and Leffler, 1989; Faraci and Breese,
1993; Shibata et al., 1990). Additionally, the application of NMDA to the large area of the
cortex present under the cranial window as used in piglets (and rabbits), probably affected all
of the exposed neurons simultaneously and therefore would not be expected to initiate a CSD-
like episode that would progress across the cortical surface under observation. While it is
possible that widespread cortical depolarization, rather than selective depolarization of
NMDA-receptor containing neurons, occurs under the cranial window with glutamate or
NMDA application, at least in the piglet, the arteriolar effects of cortical depolarization
(Domoki et al., 1999b) are completely different than observed with application of
glutamatergic agonists in this species (Busija and Leffler, 1989; Meng et al., 1995).
Additionally, while blockade of KATP channels with glibenclamide enhances dilator effects to
CSD in rats (Shimizu et al., 2000), glibenclamide attenuates cerebral vascular responses to
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NMDA (Philip and Armstead, 2004). Thus, it appears that in mice, but probably not in other
species under normal conditions, NMDA decreases cerebrovascular resistance via mechanisms
that are not related to initiation or propagation of CSD, but rather involve the selective, direct
activation of NMDA-containing neurons.
5.2. Direct effects of glutamate and NMDA receptor agonists on cerebral arteries
Fiumana et al., (2003) reported that both glutamate and 1-aminocyclopentane-cis-1,3-
dicarboxylic acid (cis-ACPD), the latter a putative NMDA receptor agonist, dilated isolated
arteries up to 15–20% via generation and actions of CO. Thus, cell types specific to the
vasculature rather than neurons were the apparent targets of glutamate and cis-ACPD and the
dilator agents were produced solely within the vascular wall. This study contrasts with all other
studies done in isolated cerebral arteries from a variety of species. Additionally, these authors
indicated an essential role of the endothelium since glutamate-induced dilation of isolated
piglet arteries was reversed to constriction following endothelial denudation. Whether cis-
ACPD continued to dilate these arteries following endothelium denudation was not reported.
Unfortunately, our laboratory has been unable to replicate the results for glutamate or NMDA
on isolated piglet arteries and arterioles, not only at physiological doses, but at pharmacological
doses as well (Simandle et al., 2005). Furthermore, we have shown that NMDA-induced
dilation in vivo was still intact following impairment of endothelial function (Domoki et al.,
2002). Other authors similarly have shown that NMDA does not dilate isolated cerebral arteries
from rabbit (Faraci and Breese, 1993), rat (Hardebo et al., 1989; Takayasu and Dacey, 1989),
cat (Hardebo et al., 1989), cow (Wendling et al., 1996) and man (Hardebo et al., 1989) (Table
1). In addition, cerebral vascular dilator responses to glutamate, when present, may not be
specific for the R- and L- isomers of glutamate (Wendling et al., 1996), thereby indicating a
lack of specific action of this amino acid against NMDA or other glutamatergic receptors. The
reasons for these differences could involve use of different NMDA-receptor agonists or other
aspects of the experimental approach. While cis-ACPD has been reported to be a NMDA
receptor agonist, this agent apparently has not been used by other groups and its potency and
specificity for NMDA receptors has not been examined in the cerebral circulation.
It is also possible that some aspects of our experimental protocol prevented the detection of
significant NMDA or glutamate dilator responses in isolated arteries of piglets. For example,
Leffler et al. (2006a) have reported the presence of positive GFAP-immunostaining of piglet
pial arterioles and arteries (diameters up to ~200 μM), and suggested that the presence of
functionally intact astroglia associated with the vessel wall was necessary for the dilator
responses to glutamate in pressurized, isolated cerebral vessels. Thus, based upon this
publication (Leffler et al., 2006a) and an earlier one (Fiumana et al., 2003) in which it was
reported that endothelium damage prevented dilation to glutamate, functionally intact cerebral
vascular astroglia and endothelium apparently are both required for glutamate-induced dilation
of isolated arteries. This finding concerning the presence of astroglia in surface cerebral vessels
is in contrast to previous reports which limit projections of the astroglia to the glia limitans,
which apparently does not penetrate the pia and arachnoid layers of the meninges where the
pial blood vessels are located, and to the exterior of parenchymal blood vessels distal to the
Virchow-Robins space (Mercier and Hatton, 2002; Niermann et al., 2001). The surface
resistance vessels of the cerebral cortex are tightly bound by the pia to the underlying glia
limitans and it is possible that positive GFAP immunostaining is due to extravascular
contamination by attached cortical astroglia during removal of the arteries and arterioles.
However, it seems unlikely that astroglia pulled off the cortical surface along with the arteries
and arterioles could be functionally intact following procedures and conditions involved in the
preparation and study of pressurized cerebral arteries in vitro. Nonetheless, this interesting
finding concerning the presence of functionally intact astroglia in surface cerebral arteries and
arterioles should be confirmed by another laboratory.
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A possible role of CO in conveying or modifying the initial NO signal from NMDA receptor
containing neurons in the cortex to vascular smooth muscle cannot be excluded especially when
glutamate is administered. Histological examination of the cortical areas underlying pial
arterioles indicate that NMDA receptors and brain NOS are located on different neurons (Bari
et al., 1998) and thus a multi-cellular sequence of events involving adjacent neurons and
perhaps astroglia is likely required for the generation of dilator agents responsible for the
vascular response. Glutamate in particular can have effects on multiple cell types in brain either
via actions on metabotropic and inotropic receptors, or as a consequence of uptake and
metabolism by astroglia (Schousboe and Waagepetersen, 2005). Further evidence for a multi-
cellular mechanism also is suggested by studies by Phililp and Armstead (2004b), where
blockade of ATP-sensitve potassium (KATP) channels or calcium-activated potassium (KCa)
channels both reduce dilation to NMDA application, although the contribution of KATP
channels is much greater. There are other examples of multiple cell types mediating
cerebrovascular dilation to physiological stimuli. For example, we have shown that in CSD-
induced cerebrovascular dilation in rabbits, cortically derived NO, perivascular nerve derived
calcitonin gene-related peptide, and prostaglandins from parenchyma and/or blood vessels all
contribute to the final blood flow response (Colonna et al., 1993; 1994; 1997).
Interpretation of data from recent studies in piglet by Leffler and colleagues (Leffler et al.,
2005; 2006a) leads to the suggestion that nitric oxide availability and related intracellular
actions represent mandatory components linking activation of glutamatergic receptors to CO-
mediated cerebral vascular dilation. In support of this theory are findings that indicate that the
NO donor, sodium nitroprusside, increases CO levels in piglet cerebral microvessels to the
same extent as glutamate (Leffler et al., 2005) and that CO apparently dilates piglet pial
arterioles via activation of smooth muscle KCa channels (Barkoudah et al., 2004). On the other
hand, Armstead (1997) has reported that the KCa channel inhibitor, iberiotoxin, which should
block CO-mediated smooth muscle responses, does not affect pial arteriolar dilation following
sodium nitroprusside administration in piglets. Production of CO also appears to occur
following activation of AMPA receptors in rat and piglet cerebral cortex (Ohata et al., 2006;
Robinson et al., 2002). On the other hand, there are contrasting findings in which it was shown
that CO inhibits NOS activity in rat cerebral arteries and cultured porcine endothelial cells
(Ishikawa et al., 2005). Additionally, a role of CO in control of the adult cerebral circulation,
especially in the rat, has been discounted by recent experiments (Andressen et al., 2006). Thus,
this interesting area needs additional research in order to more precisely define the possible
role of CO in glutamatergic receptor-induced vasodilation in the cerebral circulation.
6. Conclusions
Activation of all three types of ionotropic receptors on neurons by glutamatergic agonists leads
to dilation of cerebral resistance vessels and provides the foundation for tight coupling between
metabolic demand and blood flow in brain. Glutamate appears to preferentially activate NMDA
receptors in cortex, and the preponderance of evidence indicates that NMDA receptor
activation leads to depolarization of cortical neurons and enhanced production of NO from
those or adjacent neurons. The NO produced by neurons then diffuses relatively long distances
to cerebral arterioles and arteries and relaxes vascular smooth muscle apparently without the
contribution of vasoactive substances from endothelium, perivascular nerves, or astroglia.
While NO appears to be the predominant, perhaps initiating component of the cascade of events
leading to cerebrovascular dilator responses following NMDA-receptor activation of cortical
neurons, it appears likely that additional vasoactive agents such as adenosine and cytochrome
p-450 monooxygenase products also make important contributions, especially in rats.
However, the potential contribution of astroglial- or endothelial-derived CO especially in the
neonate in response to glutamate deserves further consideration.
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Figure 1.
Schematic illustration of likely mechanisms linking activation of neuronal NMDA receptors
in the cerebral cortex to dilation of cerebral arteries and arterioles. NMDA or glutamate
activates NMDA receptors on neurons, and following intercellular signaling to nNOS
containing neurons, nitric oxide (NO) NO is produced which diffuses to arteries and arterioles
and causes vasodilation. This intercellular transmission is blocked by tetrodotoxin (TTX), and
the NMDA rceptors can be impaired by actions of reactive oxygen species (ROS). It seems
likely that other dilator agents in addition to NO such as adenosine and P-450 monooxygenase
products also are involved especially in some species. The role of carbon monoxide (CO)
derived from astroglia remains controversial.
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